Ethical considerations in deep brain stimulation for psychiatric illness JOURNAL OF CLINICAL NEUROSCIENCE Grant, R. A., Halpern, C. H., Baltuch, G. H., O'Reardon, J. P., Caplan, A. 2014; 21 (1): 1-5


Deep brain stimulation (DBS) is an efficacious surgical treatment for many conditions, including obsessive-compulsive disorder and treatment-resistant depression. DBS provides a unique opportunity to not only ameliorate disease but also to study mood, cognition, and behavioral effects in the brain. However, there are many ethical questions that must be fully addressed in designing clinical research trials. It is crucial to maintain sound ethical boundaries in this new era so as to permit the proper testing of the potential therapeutic role DBS may play in ameliorating these devastating and frequently treatment-refractory psychiatric disorders. In this review, we focus on the selection of patients for study, informed consent, clinical trial design, DBS in the pediatric population, concerns about intentionally or inadvertently altering an individual's personal identity, potential use of DBS for brain enhancement, direct modification of behavior through neuromodulation, and resource allocation.

View details for DOI 10.1016/j.jocn.2013.04.004

View details for Web of Science ID 000330149900001

View details for PubMedID 24055023